ProfileGDS5678 / 1424051_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 95% 96% 96% 96% 99% 99% 98% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.396298
GSM967853U87-EV human glioblastoma xenograft - Control 210.187698
GSM967854U87-EV human glioblastoma xenograft - Control 310.119998
GSM967855U87-EV human glioblastoma xenograft - Control 410.402798
GSM967856U87-EV human glioblastoma xenograft - Control 510.553398
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 18.4026495
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 28.6476796
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 38.8944996
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 48.7684396
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.800299
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.068899
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.721798
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.085699
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.735699